Digital repository of Slovenian research organisations

Show document
A+ | A- | SLO | ENG

Title:Anemija pri bolnikih z rakom
Authors:Škrbinc, Breda (Author)
Južnič Šetina, Tanja (Author)
Language:Slovenian
Tipology:1.04 - Professional Article
Organisation:Logo OI - Institute of Oncology
Abstract:Anemija ali slabokrvnost je bolezensko stanje, pri katerem je zmanjšana celotna masa eritrocitov v krvnem obtoku, zaradi česar se zmanjša tudi sposobnost krvi za prenos kisika. Glavni vzroki anemije so zmanjšana tvorba eritrocitov, povečana razgradnja eritrocitov in krvavitev. Anemija, ki se pojavlja pri 30 do 90 % bolnikov z rakom je navadno posledica kombinacije več vzrokov, najpogosteje vpliva citokinov, ki se sproščajo ob maligni bolezni in mielosupresivnega učinka specifičnega onkološkega zdravljenja. Anemijo tudi pri bolnikih z rakom opredelimo po standardnih diagnostičnih postopkih, zdravljenje pa je odvisno od bolnikovih simptomov, stopnje anemije, hitrosti njenega nastanka, spremljajočih bolezni in ciljev zdravljenja bolnika z rakom. Najpogosteje uporabljamo transfuzijo koncentriranih eritrocitov in rekombinantne eritropoetine (EPA).
Year of publishing:2010
COBISS_ID:968827 Link is opened in a new window
UDC:616-006.6:616.15
ISSN on article:1408-1741
OceCobissID:65324032 Link is opened in a new window
URN:URN:NBN:SI:doc-W6T1NZXH
Views:2341
Downloads:509
Files:.pdf PDF - Presentation file, download (152,06 KB)
 
Journal:Onkologija
Onkološki inštitut
 
Metadata:XML RDF-CHPDL DC-XML DC-RDF
Rights:by Authors
:
  
Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.


Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:31.08.2018

Secondary language

Language:English
Title:Anemia in Cancer Patients
Abstract:Anemia is defined as a significant reduction of the red cell mass and a corresponding decrease of the oxigen-carrying capacity of the blood. The etiology of anemia can be due to decreased red blood cell (RBC) production, increased RBC destruction and blood loss. Anemia is prevalent in 30-90 % of cancer patients with a number of factors that may contribute to its developement, most often overexpression of inflammatory cytokines accompanying malignant disease and mielosuppressive cancer treatment. Anemia in cancer patients should be identified by standard diagnostic procedures. Decision about treatment of cancer related anemia depends on the patient's symptoms, degree of anemia and the rate at which it has evolved, patient's comorbidities and the goal of cancer treatment in a certain patient. Management of anemia in cancer patients includes the transfusion of packed red blood cells and / or the administration of recombinant erythropoetin.

Archive

niGradiv

Back